242 filings
Page 11 of 13
8-K
iuo1vza890
8 Jun 17
CRISPR Therapeutics Appoints James R. Kasinger as General Counsel
12:00am
8-K
x91xb
2 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
eal38j62
11 May 17
Results of Operations and Financial Condition
12:00am
8-K
l9jkyl 5tu
4 May 17
Departure of Directors or Certain Officers
12:00am
8-K
j4f9nzi 7g
27 Apr 17
Intellia Therapeutics and CRISPR Therapeutics Announce
12:00am
DEFA14A
mc5y4 5ib
18 Apr 17
Additional proxy soliciting materials
12:00am
DEF 14A
yqf87dhmy7eu
18 Apr 17
Definitive proxy
12:00am
8-K
2xq6vq8nxip
13 Apr 17
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision
12:00am
PRE 14A
rurhyla0 9qhfh00ujuv
4 Apr 17
Preliminary proxy
12:00am
8-K
7e2szcb51efq1 pk
31 Mar 17
CRISPR Therapeutics Announces European Patent
12:00am
8-K
tjhfpamny
20 Mar 17
Departure of Directors or Certain Officers
12:00am
10-K
od4yg cw1qen
10 Mar 17
Annual report
12:00am
8-K
pe95m64
15 Feb 17
Other Events
12:00am
CT ORDER
hqarzrks5
13 Jan 17
Confidential treatment order
12:00am
8-K
efzbj ctbzi1
16 Dec 16
Entry into a Material Definitive Agreement
12:00am
10-Q
i8l9elii8dm600adgs
22 Nov 16
Quarterly report
12:00am
8-K
wmz rk0pt64fcl2xh
8 Nov 16
Amendments to Articles of Incorporation or Bylaws
12:00am
D
go747j
4 Nov 16
$35M in equity, sold $35M, 1 investor
12:00am
S-8
m5xdrak6
20 Oct 16
Registration of securities for employees
12:00am